Clinical Trials Directory

Trials / Completed

CompletedNCT01915446

Kidney and Intestinal Markers for Early Detection of Organ Injury After Endovascular Aortic Repair

Kidney and Intestinal Markers for Early Detection of Organ Injury After Endovascular Aortic Repair - The KISMED Study

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
University Hospital Regensburg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the predictive value of novel biomarkers and contrast-enhanced ultrasonography for early detection of abdominal end-organ (kidney and intestinum) hypoperfusion and ischemia in patients undergoing endovascular aortic repair (EVAR) for aortic aneurysm or dissection. In this context, patients will be monitored for renal biomarkers (TIMP-2, IGFBP7) and intestinal biomarkers (plasmatic intestinal fatty acid binding protein (i-FABP)) and local tissue perfusion will be assessed using contrast-enhanced ultrasonography (CEUS). The ultimate goal of this study is an early identification of patients developing one or both of these complications, which may facilitate a timely intervention to improve outcome.

Conditions

Timeline

Start date
2013-07-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2013-08-05
Last updated
2014-12-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01915446. Inclusion in this directory is not an endorsement.